These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2920853)

  • 21. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
    Badawy SZ; Marziale JC; Rosenbaum AE; Chang JK; Joy SE
    Early Pregnancy; 1997 Dec; 3(4):306-11. PubMed ID: 10086082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Macroprolactinoma reduction and pregnancy induction with bromocriptine].
    Grimaldo J; López Espinoza E; Villanueva C; Verulo Reyes TB; Ayala AR
    Ginecol Obstet Mex; 1988 Aug; 56():213-7. PubMed ID: 3154241
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of pregnancy on the serum prolactin level following prolactinoma surgery.
    Hirohata T; Uozumi T; Mukada K; Arita K; Kurisu K; Yano T; Takechi A; Onda J
    Acta Endocrinol (Copenh); 1991 Sep; 125(3):259-67. PubMed ID: 1950339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 25. Prolactinoma in an adolescent girl: unusual response to bromocriptine therapy.
    Tiwary CM
    Am J Dis Child; 1989 May; 143(5):521-3. PubMed ID: 2718982
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolactinoma.
    Serri O; Beauregard H; Somma M
    Curr Ther Endocrinol Metab; 1994; 5():41-3. PubMed ID: 7704764
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
    Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
    Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromocriptine in obstetrics and gynaecology.
    Haider P
    J Pak Med Assoc; 1990 Sep; 40(9):224-9. PubMed ID: 2123273
    [No Abstract]   [Full Text] [Related]  

  • 29. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 30. NK activity in patients with pathological hyperprolactinemia: effect of bromocriptine.
    Honorati MC; Travaglini P; De Bernardi B; Scorza R; Hu C; Togni ME; Radelli L; Vanoli M; Zanussi C
    Int J Neurosci; 1990 Apr; 51(3-4):303-5. PubMed ID: 2279890
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical treatment of hyperprolactinemia.
    Fossati P; Dewailly D; Thomas-Desrousseaux P; Buvat J; Fermon C; Lemaire A; Bourdelle-Hego MF; Pouyol-Motte H; Lemaitre G; Clarisse J
    Horm Res; 1985; 22(3):228-38. PubMed ID: 4054843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of hyperprolactinemic women treated with bromocriptine.
    Corenblum B; Taylor PJ
    Fertil Steril; 1983 Nov; 40(5):596-9. PubMed ID: 6628704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endocrinologic diseases management during breastfeeding].
    Serrano Aguayo P; García de Quirós Muñoz JM; Bretón Lesmes I; Cózar León MV
    Med Clin (Barc); 2015 Jan; 144(2):73-9. PubMed ID: 25073822
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperprolactinemia and lens opacities.
    Costagliola C; Mastropasqua L; Amato G; Carella C
    Ann Ophthalmol; 1992 Nov; 24(11):418-9. PubMed ID: 1476397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic results in hyperprolactinemic sterility patients].
    Melzer H
    Zentralbl Gynakol; 1987; 109(8):517-20. PubMed ID: 3604494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal prolactin levels and pituitary-gonadal axis in the puerperium.
    Andersen AN; Tabor A; Hertz JB; Schiøler V
    Obstet Gynecol; 1981 Jun; 57(6):725-9. PubMed ID: 7231824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.